首页> 外文会议>International Conference on Intelligent Systems and Knowledge Engineering >English Drug Name Entity Recognition Method Based on Attention Mechanism BiLSTM-CRF
【24h】

English Drug Name Entity Recognition Method Based on Attention Mechanism BiLSTM-CRF

机译:基于注意机制BiLSTM-CRF的英文药物名称实体识别方法

获取原文

摘要

Drug Name Entity Recognition (DNER) in biomedical literature is the basis of drug information extraction. Existing drug name entity recognition methods depend heavily on hand-designed features and domain knowledge. To avoid tedious features engineering, an attention based BiLSTM-CRF English drug name entity recognition method is proposed. Firstly, in BiLSTM, Words are learned at character level vectors and Word level vectors are obtained, Which are joined together and input into the attention mechanism. Then, the vectors containing the semantic and syntactic roles of Words are learned by LSTM, truncated and input into the attention mechanism. Finally, the attention mechanism dynamically determines the Weights of the two inputs through matrix. The Weights obtained are put into the CRF layer for joint decoding to do sentence classification and prediction. Experiments on the corpus of 2013DDI Extraction show that the F1 value of the model is 80.06%.
机译:生物医学文献中的药物名称实体识别(DNER)是药物信息提取的基础。现有的药品名称实体识别方法在很大程度上取决于手工设计的功能和领域知识。为了避免繁琐的特征工程,提出了一种基于注意力的BiLSTM-CRF英语药品名称实体识别方法。首先,在BiLSTM中,单词是在字符级别的向量上学习的,并且获得了单词级别的向量,将它们连接在一起并输入到注意力机制中。然后,通过LSTM学习包含单词的语义和句法作用的向量,将其截断并输入到注意力机制中。最后,注意力机制通过矩阵动态确定两个输入的权重。将获得的权重放入CRF层以进行联合解码,以进行句子分类和预测。对2013DDI Extraction的语料库进行的实验表明,该模型的F1值为80.06%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号